PheroBioSource OÜ

Active Registry code 16632127 OÜ Tartu linn Registered 14 Dec 2022
Compare

PheroBioSource OÜ is a OÜ based in Tartu linn, registry code 16632127, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with employees.

Turnover
0 €
State taxes
72 €
↑ 75.6% vs Q2 2026
Labour taxes
0 €
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 1 258 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 10.6 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
05 00010 00015 00020 000Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: 0 € Industry median: 14 999 €Q2·24Q3 2024 Company: 0 € Industry median: 11 985 €Q4 2024 Company: 0 € Industry median: 16 752 €Q4·24Q1 2025 Company: 1 460 € Industry median: 15 203 €Q2 2025 Company: 0 € Industry median: 14 420 €Q2·25Q3 2025 Company: 0 € Industry median: 13 763 €Q4 2025 Company: 0 € Industry median: 13 976 €Q4·25Q1 2026 Company: 1 258 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26Q3 2026 Company: 0 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q4 2024 Company: 0 € Industry median: 16 752 €Q1 2025 Company: 1 460 € Industry median: 15 203 €Q1·25Q2 2025 Company: 0 € Industry median: 14 420 €Q3 2025 Company: 0 € Industry median: 13 763 €Q3·25Q4 2025 Company: 0 € Industry median: 13 976 €Q1 2026 Company: 1 258 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q3 2026 Company: 0 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q3 2026: 72 € · +75.6% vs Q2 2026
020406080Q4 2023 Company: 0 €Q4·23Q1 2024 Company: 0 €Q2 2024 Company: 0 €Q2·24Q3 2024 Company: 0 €Q4 2024 Company: 0 €Q4·24Q1 2025 Company: 0 €Q2 2025 Company: 0 €Q2·25Q3 2025 Company: 0 €Q4 2025 Company: 0 €Q4·25Q1 2026 Company: 54 €Q2 2026 Company: 41 €Q2·26Q3 2026 Company: 72 €Q3·26020406080Q4 2024 Company: 0 €Q1 2025 Company: 0 €Q1·25Q2 2025 Company: 0 €Q3 2025 Company: 0 €Q3·25Q4 2025 Company: 0 €Q1 2026 Company: 54 €Q1·26Q2 2026 Company: 41 €Q3 2026 Company: 72 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 72 — —
Q2 2026 — 41 — —
Q1 2026 1 258 54 — —
Q4 2025 — — — —
Q3 2025 — — — —
Q2 2025 — — — —
Q1 2025 1 460 — — —
Q4 2024 — — — —
Q3 2024 — — — —
Q2 2024 — — — —
Q1 2024 — — — —
Q4 2023 — — — —
Q3 2023 3 167 — — —
Q2 2023 11 594 — — —
Q1 2023 2 240 — — —

Financials by year

2023 – 2025
Revenue, € 2025: 1 258 € · −13.8% vs 2024 · industry median 0 € · above 57% of the industry
010 00020 00030 00040 0002023 Company: 35 240 € Industry median: 80 €20232024 Company: 1 460 € Industry median: 0 €20242025 Company: 1 258 € Industry median: 0 €2025010 00020 00030 00040 0002023 Company: 35 240 € Industry median: 80 €20232024 Company: 1 460 € Industry median: 0 €2025 Company: 1 258 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 133 € · −72.4% vs 2024 · industry median 0 € · above 58% of the industry
01 0002 0003 0004 0005 0002023 Company: 4 016 € Industry median: 0 €20232024 Company: 482 € Industry median: 0 €20242025 Company: 133 € Industry median: 0 €202501 0002 0003 0004 0005 0002023 Company: 4 016 € Industry median: 0 €20232024 Company: 482 € Industry median: 0 €2025 Company: 133 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 10.6 % · −22.4 pp vs the year before · industry median 13.5 % · above 47% of the industry
0102030402023 Company: 11.4 % Industry median: 16.8 %20232024 Company: 33.0 % Industry median: 15.8 %20242025 Company: 10.6 % Industry median: 13.5 %20250102030402023 Company: 11.4 % Industry median: 16.8 %20232024 Company: 33.0 % Industry median: 15.8 %2025 Company: 10.6 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 5 135 € · −82.9% vs 2024
010 00020 00030 00040 0002023 Company: 30 687 €20232024 Company: 30 002 €20242025 Company: 5 135 €2025010 00020 00030 00040 0002023 Company: 30 687 €20232024 Company: 30 002 €2025 Company: 5 135 €2025
Equity, € 2025: 1 882 € · +7.6% vs 2024
05001 0001 5002 0002023 Company: 1 266 €20232024 Company: 1 749 €20242025 Company: 1 882 €202505001 0001 5002 0002023 Company: 1 266 €20232024 Company: 1 749 €2025 Company: 1 882 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.20.40.60.81.02023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.20.40.60.81.02023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 1 258 133 0 5 135 1 882 0
2024 1 460 482 0 30 002 1 749 0
2023 35 240 4 016 0 30 687 1 266 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
10.6 %
Net profit / revenue
Return on equity (ROE)
7.1 %
Net profit / equity
Return on assets (ROA)
2.6 %
Net profit / assets
Equity ratio
36.7 %
Equity / assets
Debt ratio
63.3 %
Liabilities / assets
Current ratio
1.16
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 22 May 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 25 Apr 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 13 Jun 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main
Rulings
Number, date Title Deadline State Document
Ä 50217115 / 6
3 Feb 2025
Amendment entry In force
3 Feb 2025
PDF
Ä 50217115 / 5
27 Jan 2025
Amendment entry In force
27 Jan 2025
PDF
Ä 50217115 / 4
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50217115 / 3
15 Jun 2023
Amendment entry In force
15 Jun 2023
PDF
Ä 50217115 / 2
12 Jun 2023
Amendment entry In force
12 Jun 2023
PDF
Ä 50217115
14 Dec 2022
First entry In force
14 Dec 2022
PDF

Sources: e-Äriregister and EMTA. Data updated 27 Oct 2026. Open at the source ↗ · Report an error in the data